Advertisement

Topics

Cipla Primes For US Momentum But Seretide Generic Is Slow In UK

08:07 EST 8 Nov 2017 | SCRIP

Cipla reported a strong second quarter, with management upbeat about building momentum in the US business with a “good mix”...

      

Related Stories

 

Original Article: Cipla Primes For US Momentum But Seretide Generic Is Slow In UK

NEXT ARTICLE

More From BioPortfolio on "Cipla Primes For US Momentum But Seretide Generic Is Slow In UK"

Advertisement
Quick Search
Advertisement
Advertisement